WHAT IF WE COULD CREATE A WORLD FREE OF DISEASE?

AT THE iQ GROUP GLOBAL,

That’s all we think about

We are a consortium of companies who work together to find, fund and develop bioscience discoveries into life-changing medical innovations – and take them to the people who need them most.

FIND

Our scientific team identifies scientific discoveries from laboratories all over the world that have the potential to have life-changing impact.

FUND

Our corporate advisory and investment banking teams work together to translate scientific milestones into value creation events, creating financial instruments and corporate structures that activate commercial value.

DEVELOP

Our commercialization team partners with healthcare providers and unlocks regulatory pathways to take the discovery to the people who need it.

OUR INNOVATIONS

TEX Core

Oncology Platform

An Australian-owned world-first cancer fighting treatment.

Learn More

At The iQ Group Global, we are committed to transforming current cancer treatments, with our oncology drug platform TEX Core, by directly targeting tumours whilst minimizing the toxic side-effects of traditional platinum-based chemotherapy.

From the TEX Core platform, our ovarian cancer-fighting drug OxaliTEX has the proven ability to kill cancer cells, even in platinum resistant tumours with preclinical data showing the drug to be more effective than traditional chemotherapy treatments.

We are on a mission to recreate the way we fight cancer to build a new hope for ovarian cancer patients globally.

The Biosensor

Diagnostic Platform

The Biosensor platform is a small, organic strip that will put the power of accurate, timely diagnosis in the hands of patients and their primary health practitioners.

Learn More

The Holy Grail World-First Needle-Free Diabetes Test

The Saliva Glucose Biosensor is the world’s first non-invasive, saliva-based glucose test for diabetes management that measure glucose in saliva, not blood. Our innovative technology will free people living with diabetes from having to use painful and invasive blood monitoring devices to manage their condition, giving them a better quality of life.